tiprankstipranks
Kobayashi Pharmaceutical Co Ltd (JP:4967)
:4967
Japanese Market
4967
Kobayashi Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4967 full AI Analyst Report?

Kobayashi Pharmaceutical Co (4967) Ratios

0 Followers

Kobayashi Pharmaceutical Co Ratios

JP:4967's free cash flow for Q2 2025 was ¥0.53. For the 2025 fiscal year, JP:4967's free cash flow was decreased by ¥ and operating cash flow was ¥0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.04 2.47 3.11 2.82 3.34
Quick Ratio
 2.41 2.10 2.59 2.43 3.00
Cash Ratio
 1.35 1.04 1.10 1.27 1.86
Solvency Ratio
 0.25 0.19 0.35 0.42 0.44
Operating Cash Flow Ratio
 0.00 0.43 0.24 0.33 0.62
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 48.44 122.28
Net Current Asset Value
¥ 81.65B¥ 84.50B¥ 92.57B¥ 95.67B¥ 114.96B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.22 1.30 1.24 1.31 1.29
Debt Service Coverage Ratio
 31.45 444.04 647.18 64.77 91.04
Interest Coverage Ratio
 490.71 532.96 887.86 888.97 1.48K
Debt to Market Cap
 <0.01 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
 10.16 9.50 11.76 13.40 10.50
Net Debt to EBITDA
 -4.67 -4.92 -2.28 -2.10 -2.86
Profitability Margins
Gross Profit Margin
51.02%51.11%52.90%55.56%55.53%
EBIT Margin
2.02%2.28%8.42%15.90%16.82%
EBITDA Margin
7.18%7.55%13.26%19.40%20.04%
Operating Profit Margin
8.24%9.00%15.01%14.86%16.04%
Pretax Profit Margin
2.24%2.26%8.40%15.89%16.81%
Net Profit Margin
1.84%2.21%6.08%11.73%12.04%
Continuous Operations Profit Margin
1.84%2.21%6.08%11.73%12.04%
Net Income Per EBT
82.10%97.68%72.36%73.80%71.64%
EBT Per EBIT
27.20%25.08%55.97%106.90%104.80%
Return on Assets (ROA)
1.20%1.33%3.79%7.60%7.83%
Return on Equity (ROE)
1.46%1.73%4.72%9.93%10.12%
Return on Capital Employed (ROCE)
6.45%6.93%11.35%12.20%13.07%
Return on Invested Capital (ROIC)
5.30%6.77%8.21%8.97%9.34%
Return on Tangible Assets
1.29%1.42%4.11%8.27%8.26%
Earnings Yield
0.70%0.91%2.17%3.95%2.88%
Efficiency Ratios
Receivables Turnover
 4.99 3.18 3.35 3.27 3.47
Payables Turnover
 7.70 5.44 5.31 8.81 8.17
Inventory Turnover
 3.08 3.56 3.23 3.49 4.18
Fixed Asset Turnover
 2.44 2.46 2.46 3.64 4.78
Asset Turnover
 0.65 0.60 0.62 0.65 0.65
Working Capital Turnover Ratio
 1.91 1.78 1.65 1.55 1.32
Cash Conversion Cycle
 144.12 150.19 153.19 174.65 147.65
Days of Sales Outstanding
 73.13 114.81 108.85 111.49 105.06
Days of Inventory Outstanding
 118.39 102.49 113.07 104.56 87.28
Days of Payables Outstanding
 47.39 67.11 68.73 41.41 44.69
Operating Cycle
 191.51 217.30 221.92 216.06 192.34
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 344.24 151.28 242.08 413.81
Free Cash Flow Per Share
 0.00 165.96 -199.23 63.17 203.38
CapEx Per Share
 0.00 178.28 350.51 178.91 210.43
Free Cash Flow to Operating Cash Flow
 0.00 0.48 -1.32 0.26 0.49
Dividend Paid and CapEx Coverage Ratio
 0.00 1.22 0.34 0.88 1.40
Capital Expenditure Coverage Ratio
 0.00 1.93 0.43 1.35 1.97
Operating Cash Flow Coverage Ratio
 0.00 37.74 13.29 18.60 40.30
Operating Cash Flow to Sales Ratio
 0.00 0.15 0.07 0.11 0.19
Free Cash Flow Yield
0.00%3.06%-3.20%0.93%2.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 141.87 110.37 46.00 25.32 34.78
Price-to-Sales (P/S) Ratio
 2.61 2.43 2.80 2.97 4.19
Price-to-Book (P/B) Ratio
 2.08 1.91 2.17 2.51 3.52
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 32.71 -31.27 107.49 44.40
Price-to-Operating Cash Flow Ratio
 0.00 15.77 41.18 28.05 21.82
Price-to-Earnings Growth (PEG) Ratio
 -1.99 -1.73 -0.93 7.69 12.09
Price-to-Fair Value
 2.08 1.91 2.17 2.51 3.52
Enterprise Value Multiple
 31.65 27.31 18.81 13.21 18.03
Enterprise Value
 379.25B 341.87B 413.10B 444.42B 600.97B
EV to EBITDA
 31.65 27.31 18.81 13.21 18.03
EV to Sales
 2.27 2.06 2.49 2.56 3.61
EV to Free Cash Flow
 0.00 27.71 -27.89 92.76 38.31
EV to Operating Cash Flow
 0.00 13.36 36.73 24.21 18.83
Tangible Book Value Per Share
 2.58K 2.60K 2.59K 2.42K 2.39K
Shareholders’ Equity Per Share
 2.81K 2.84K 2.87K 2.70K 2.57K
Tax and Other Ratios
Effective Tax Rate
 0.18 0.02 0.28 0.26 0.28
Revenue Per Share
 2.24K 2.23K 2.23K 2.29K 2.16K
Net Income Per Share
 41.27 49.18 135.42 268.16 259.61
Tax Burden
 0.82 0.98 0.72 0.74 0.72
Interest Burden
 1.11 0.99 1.00 1.00 1.00
Research & Development to Revenue
 0.05 0.06 0.06 0.05 0.05
SG&A to Revenue
 0.33 0.33 0.29 0.17 0.03
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 7.00 1.12 0.90 1.14
Currency in JPY